Late Breaking News
Department of Veterans Affairs (VA)
What is the Survival Benefit of PSA Testing?
The question of how and when prostate-specific antigen (PSA) screening for prostate cancer should be used, if at all, is being debated across the medical establishment. Those arguments — and any resolution — will have a significant effect on the VA, which diagnoses more than 12,000 new cases of prostate cancer each year.
Two researchers are trying to better understand the relationship between mental-health issues and lower urinary tract symptoms. Their work in the area began after observing that servicemembers returning from Iraq and Afghanistan had complaints similar to older patients, including urgent incontinence.
SALT LAKE CITY, UT – Two new studies may offer important clues as to why suicide rates are on the increase among military personnel and veterans.
ATLANTA — Multiple mental health-related deaths at the Atlanta VAMC have led to bipartisan demands from Congress that care and leadership issues be urgently resolved at the facility.
WASHINGTON —With a potential billion dollars at stake, the VA is under fire for not addressing overpayments to veterans with temporary disability ratings whose conditions are not re-evaluated in a timely manner.
WASHINGTON — In the wake of a recent federal report finding that schedules have been delayed and costs substantially increased for VA medical construction projects in Las Vegas, Denver, Orlando and New Orleans, a key legislator called the agency’s construction program “dysfunctional.”
VA Researchers Find Sex-Based Differences in Disorder
SAN FRANCISCO — Why are women so much more likely than men to develop post-traumatic stress disorder? The answer could be differences in the way men and women develop fear responses, according to VA researchers.
Hypopituitarism May Cause Insomnia, Reduced Libido, Depression
SEATTLE — For the 30% of warriors with concussive injuries whose symptoms fail to resolve in a few months, recent research offers new hope.
ANN ARBOR, MI — For nearly two years, the Food and Drug Administration has been issuing safety advisories about the risks of abnormal heart rhythms with higher doses of the antidepressant citalopram hydrobromide.
Most Popular Stories
- Many Healthcare Providers Lose VA Retention Bonuses
- Federal Medicine Organizational Meetings — Tarred with the Same Brush?
- Despite Formulary, High-Cost Diabetes Drug Use Varies Widely Across VA Facilities
- Report Says Administration Faces Hard Choices For Veterans Programs
- Physician Overcomes TBI to Return to Active-Duty Medicine
Join Our E-Mail List